sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Two Upcoming Conferences
Jaguar Health, Inc., a San Francisco-based pharmaceutical company, has announced participation in two key conferences in December 2024. Lisa Conte, the company's founder and CEO, will represent Jaguar Health. The engagements include an in-person presentation at NobleCon20 on December 3, followed by a virtual appearance at the Emerging Growth Conference on December 5. These opportunities allow Jaguar Health to showcase its efforts in developing novel gastrointestinal medications derived from rainforest plants.
The NobleCon20 presentation will take place at Florida Atlantic University's Executive Education Complex. Conference participants can access a replay of the session online after the event. Details for both conference participations are available on respective websites and platforms, allowing widespread access to Jaguar Health's initiatives and developments in the pharmaceutical landscape.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.